Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

CTMX CytomX Therapeutics Inc

1,46

0,04 (2,82%)

Nach Börsenschluss

Zuletzt aktualisiert: 01:22:57

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Click Here for more CytomX Therapeutics Charts.

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024

Click Here for more CytomX Therapeutics Charts.

News CytomX Therapeutics Inc

CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Dienstag 18 Juni 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 17 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)

CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
Montag 17 Juni 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 14 Juni 2024 (1 Monat vor) • Edgar (US Regulatory)

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
Mittwoch 22 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 17 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 17 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

CytomX Therapeutics Announces New Employment Inducement Grants
Donnerstag 16 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere CytomX Therapeutics Inc News-Artikel

Euro vs Sterling

Financial Select Sector

Invesco QQQ Trust Series 1

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen